Periodic Reporting for period 1 - CURE-PDAC (Acceleration of the world’s first autotaxin inhibitor for the treatment of pancreatic cancer (PDAC))

Pancreatic cancer is one of the most aggressive and lethal cancers, with a 5-year survival rate of only 12%. Currently, treatments for pancreatic cancer are largely ineffective due to the high degree of stromal fibrotic scar tissue in the tumor. This acts as a physical barrier...